Cumulatively, the protective effect of Carvacrol against diabetic cardiomyopathy is exerted through reestablishing PI3K/AKT signaling-facilitated translocation of GLUT4 to the cell membrane [63]. The gene discussed is AKT1; the disease is diabetic cardiomyopathy.